Kraig Biocraft Laboratories, Inc. KBLB

Company Overview

Kraig Biocraft Laboratories, Inc. is a biotechnology materials company focused on the development and commercialization of genetically engineered spider silk fibers and advanced recombinant silk technologies. The company operates primarily in the biomaterials and performance textiles industries, using genetic engineering techniques to produce silk fibers with characteristics associated with natural spider silk, including high tensile strength, elasticity, and lightweight performance. Kraig Biocraft Laboratories generates value through the research, development, production, and anticipated commercialization of proprietary silk-based materials intended for technical textiles, defense applications, medical materials, and specialty apparel markets.

The company’s principal business activities center on engineered silkworm strains designed to produce recombinant spider silk proteins during the silk-spinning process. Its proprietary technologies and product platforms include variants marketed under names such as Dragon Silk, Monster Silk, and other recombinant silk lines. Kraig Biocraft Laboratories was founded in 2006 and is headquartered in the United States. Over time, the company evolved from an early-stage biotechnology research organization into a commercialization-focused enterprise emphasizing scaled silk production, international manufacturing partnerships, and intellectual property development related to transgenic silk technologies.